Form 4: Artivion Director Jon Salveson Receives Stock Grant

Director Jon W. Salveson was granted 7,576 shares of Artivion, Inc. common stock as part of an equity incentive plan.

Summary

• Director Jon W. Salveson acquired 7,576 shares of Artivion, Inc. (AORT) common stock.
• The transaction occurred on May 18, 2026.
• The shares were granted at a price of $0, representing a restricted stock award (RSA).
• Following this transaction, the director's total beneficial ownership is 137,416 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation and equity alignment, which is neutral for the stock price.

Positives

• The director's increased equity stake aligns personal interests with long-term shareholder value.

Negatives

• None identified.

Risks

• The vesting of the restricted stock is subject to the terms of the Equity and Cash Incentive Plan.

Future Outlook

The restricted stock grant is scheduled to vest on May 18, 2027, subject to the company's Equity and Cash Incentive Plan.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to incentivize long-term leadership commitment in the medical device sector.

Comparison to Industry Standards

• The grant of restricted stock units to board members is a common practice among mid-cap medical technology companies to ensure alignment with shareholder interests.

Stakeholder Impact

• Increased alignment between the director and shareholders.

Next Steps

• Vesting of the 7,576 shares on May 18, 2027.

Key Dates

Keywords

Artivion, AORT, Form 4, Insider Trading, Equity Incentive Plan, Director Ownership